[Somatostatin and SMS 201-995 (octreotide): clinical and therapeutic aspects].
Nowadays, the digestive system, must be considered as an actual endocrinous gland. The authors, after pointing out the pharmacological and immunomodulating actions of endogenous somatostatine, briefly describe a new synthetic octapeptid, somatostatine-analogue, with similar pharmacological effects (octreotide). Finally they stress the therapeutic trials in which the adverse effects, dosage and administration have been studied.
da Silva
P M
PM
Serviço de Medicina Interna, Hospital de Santa Marta, Lisboa.
Augusto
F
F
D006801:Humans; D015282:Octreotide / Q000494:pharmacology / Q000627:therapeutic use*; D013004:Somatostatin / Q000502:physiology*
D013004:Somatostatin; D015282:Octreotide
Somatostatina e SMS 201-995 (octreótido): aspectos clínicos e terapêuticos.